The Maternal Microbiome Programs the MA Epitranscriptome of the Mouse Fetal Brain and Intestine
Overview
Authors
Affiliations
The microbiome exerts profound effects on fetal development and health, yet the mechanisms underlying remain elusive. N6-methyladenosine (mA) plays important roles in developmental regulation. Although it has been shown that the microbiome affects the mRNA mA modification of the host, it remains unclear whether the maternal microbiome affects mA epitranscriptome of the fetus so as to impact fetal development. Here, we found that loss of the maternal microbiome altered the expression of mA writers and erasers, as well as the mA methylome of the mouse fetal brain and intestine on embryonic day 18. From the mA profiles, we identified 2,655 and 2,252 mA modifications regulated by the maternal microbiome in the fetal brain and intestine, respectively, and we demonstrated that these mA-modified genes were enriched in the neuro/intestinal developmental pathways, such as the Wnt signaling pathway. Finally, we verified that antibiotic treatment mostly recapitulated changes in mA, and we further showed that the loss of heterozygosity of rescued mA levels and the expression changes of some developmental genes in the fetal intestine that resulted from antibiotic treatment. Collectively, our data revealed that the maternal microbiome programs the mA epitranscriptome of the mouse fetal brain and intestine.
Cao Z, An Y, Lu Y Int J Mol Sci. 2024; 25(4).
PMID: 38396669 PMC: 10889299. DOI: 10.3390/ijms25041990.